BSV has developed considerable market strengths in the domestic markets through its portfolio of niche primary line, life saving injectables. The Company remains focused on ascending the value chain in the manufacturing and marketing of biological, pharmaceutical and biotechnology products and is committed to enhancing the sales of these products.

The Company has in its portfolio over 25 brands, most of them having the potential of being a product capable of being marketed in the global market. Exports would continue to propel the Company's growth in the coming years.